Barnum Medical Research Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Familial hypercholesterolaemia1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Novartis Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight

  NCT05486065· Phase 2· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· Phase 3· Novo Nordisk A/S· Source